Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation

Int J Mol Sci. 2024 Sep 29;25(19):10480. doi: 10.3390/ijms251910480.

Abstract

Acute lung Injury leads to alterations in surfactant lipid composition and metabolism. Although several mechanisms contribute to dysregulated surfactant metabolism, studies investigating in vivo surfactant metabolism are limited. The aim of this study is to characterise surfactant phospholipid composition and flux utilising a stable isotope labelling technique in mechanically ventilated paediatric patients. Paediatric patients (<16 years of age) received 3.6 mg/kg intravenous methyl-D9-choline chloride followed by the endotracheal instillation of 100 mg/kg of exogenous surfactant after 24 h. Bronchioalveolar fluid samples were taken at baseline and 12, 24, 36, 48, 72 and 96 h after methyl-D9-choline infusion. Nine participants (median age of 48 days) were recruited. The primary phosphatidylcholine (PC) composition consisted of PC16:0/16:0 or DPPC (32.0 ± 4.5%). Surfactant supplementation resulted in a 30% increase in DPPC. Methyl-D9 PC enrichment was detected after 12 h and differed significantly between patients, suggesting variability in surfactant synthesis/secretion by the CDP-choline pathway. Peak enrichment was achieved (0.94 ± 0.15% of total PC) at 24 h after methyl-D9-choline infusion. There was a trend towards reduced enrichment with the duration of mechanical ventilation prior to study recruitment; however, this was not statistically significant (p = 0.19). In this study, we demonstrated the fractional molecular composition and turnover of surfactant phospholipids, which was highly variable between patients.

Keywords: intensive care; paediatric; phospholipids; surfactant; ventilation.

MeSH terms

  • Adolescent
  • Bronchoalveolar Lavage Fluid / chemistry
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Kinetics
  • Male
  • Phosphatidylcholines / metabolism
  • Phospholipids* / metabolism
  • Pulmonary Surfactants* / administration & dosage
  • Pulmonary Surfactants* / metabolism
  • Respiration, Artificial*

Substances

  • Pulmonary Surfactants
  • Phospholipids
  • Phosphatidylcholines